FFAR3 and colorectal carcinoma: To functionally examine the role of the receptors in CD8+ T cell activation, we repeated the stimulation above following pretreatment of the CRC cells with the GPR41 blocking agent beta-hydroxybutyrate (BHB) (35–37).